What does the FDA really say about diversity in clinical trials? What do you need to do now to make sure you remain compliant? Our white paper, answers these questions and more, giving you the insight you need to successfully run a compliant, diverse study.
Related Reading
Health Equity
Women’s Health Equity Initiative
AdvaMed is dedicated to ensuring our industry focuses their efforts on treating and raising the awareness of women’s health conditions.
Resource / Health Equity
Phase III: Disparities in Access to Selected Advanced Medical Procedures in the Medicare Population
March 6, 2024
The final report of a three-part series investigates the prevalence of racial and ethnic disparities in the use of in the use of advanced interventions in the Medicare program.
Resource / Health Equity
Phase II: Literature Review: Racial Disparities in Use of Selected Medical Technologies
March 6, 2024
The second of a three-phase research series examines the difference in access to certain advanced interventions, including a range of surgical, medical and technological interventions.
Resource / Health Equity
Phase I: Disparities in Access to Advanced Medical Procedures in the Medicare Population
March 6, 2024
Racial and ethnic healthcare disparities in access to advanced interventions have persisted in the U.S. medical system. The first of a three-phase research series examines the difference in access to certain advanced interventions.
Diagnostics / Digital Health / Health Equity
American Heart Month
This February, AdvaMed is working with member companies and our global partners to raise awareness and highlight the ways medical technology helps those living with cardiovascular disease live healthier, happier lives.
Resource / Digital Health / Health Equity
Automated Point-of-Care CAR T-Cell Fabrication & Democratization
January 12, 2024
MIDI describes recent advancements their team engineered in the biopharma fabrication space.
News / Health Equity
AdvaMed Praises Administration’s “Women’s Health Research” Initiative
November 13, 2023
AdvaMed, the medtech association, today released the following statements on the White House’s announcement today of a new initiative focused on women’s health research to be led by First Lady Jill Biden. This year, AdvaMed created a Board-level committee to address health disparities more broadly, led by AdvaMed Board of Directors member Lishan Aklog, M.D., as well as a Board-level subcommittee on women’s health, led by AdvaMed Board member Tracy MacNeal. Statements from both medtech leaders follow.
Resource / Health Equity
Principles On Health Equity
October 26, 2023
We are committed to ensuring that our mission is not compromised by the perpetuation of racial health disparities.